SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 47 filers reported holding SIGILON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $62,006 | +165.7% | 66,666 | 0.0% | 0.00% | +200.0% |
| Q4 2022 | $23,333 | -31.4% | 66,666 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $34,000 | -38.2% | 66,666 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $55,000 | -43.9% | 66,666 | 0.0% | 0.00% | -40.0% |
| Q1 2022 | $98,000 | -46.7% | 66,666 | 0.0% | 0.01% | -54.5% |
| Q4 2021 | $184,000 | -51.2% | 66,666 | 0.0% | 0.01% | -54.2% |
| Q3 2021 | $377,000 | – | 66,666 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|